Tectonic Therapeutic, Inc. (TECX) Financials

TECX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 246.6 million 16.2 million
Dec. 31, 2025 261.0 million 9.7 million
Sept. 30, 2025 277.0 million 9.5 million
June 30, 2025 295.3 million 11.5 million

TECX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -18.4 million 3.2 million
Dec. 31, 2025 -14.5 million 5.1 million
Sept. 30, 2025 -18.0 million 2.8 million
June 30, 2025 -14.7 million 4.7 million

TECX Net Income

No data available :(

TECX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 236.9 million 3.2 million -
Dec. 31, 2025 253.8 million 43000 1.3 million
Sept. 30, 2025 268.4 million 100000 1.2 million
June 30, 2025 287.4 million - 1.9 million

TECX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 18.8 million
Dec. 31, 2025 18.3 million
Sept. 30, 2025 18.7 million
June 30, 2025 18.7 million

TECX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 19000 20.9 million 6.4 million -
Dec. 31, 2025 27000 16.3 million 5.2 million -
Sept. 30, 2025 181000 16.9 million 5.0 million -
June 30, 2025 27000 17.2 million 5.1 million -

TECX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - 340000

TECX

Price: $29.27

52 week price:
14.39
36.03

Earnings Per Share: -4.46 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 547.2 million

Links: